Exane Derivatives’s Eagle Materials EXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$138K Sell
1,258
-491
-28% -$60.4K 0.08% 228
2022
Q1
$224K Sell
1,749
-776
-31% -$110K 0.06% 305
2021
Q4
$420K Sell
2,525
-3,207
-56% -$493K 0.1% 203
2021
Q3
$752K Sell
5,732
-1,205
-17% -$173K 0.18% 121
2021
Q2
$959K Buy
6,937
+6,352
+1,086% +$913K 0.22% 96
2021
Q1
$78.6K Buy
585
+94
+19% +$11.4K 0.02% 457
2020
Q4
$49.8K Buy
491
+209
+74% +$19.4K 0.01% 456
2020
Q3
$24.3K Buy
+282
New +$22.8K 0.01% 420

Other funds holding EXP

Exane Derivatives's EXP Position: Q2 2022 in Review

Exane Derivatives reduced its Eagle Materials (EXP) stake by 28% in Q2 2022, selling an estimated $60.4K and leaving 1,258 shares worth $138K. The position accounts for 0.08% of the portfolio, ranked #228.

Exane Derivatives first reported a position in EXP in Q3 2020 and has held it in 8 quarters since. The position peaked at $959K in Q2 2021. 342 funds tracked by Wall St. Rank hold EXP as of Q2 2022.

  • Exane Derivatives held 1,258 shares of Eagle Materials worth $138K as of Q2 2022.
  • Exane Derivatives sold 491 Eagle Materials shares in Q2 2022, an estimated $60.4K.
  • Eagle Materials made up 0.08% of Exane Derivatives's portfolio in Q2 2022, its #228 holding.
  • Exane Derivatives first reported a position in Eagle Materials in Q3 2020 and has held it in 8 quarters since.
  • Exane Derivatives's Eagle Materials position peaked at $959K in Q2 2021.
  • 342 funds tracked by Wall St. Rank held Eagle Materials as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.